Navigation Links
Inside Job: Medical Negligence Lawyers at Console & Hollawell Comment on Risks to Dialysis Patients and Impending Legal Action Over Fresenius Controversy
Date:2/11/2013

Marlton, NJ (PRWEB) February 11, 2013

One in 10 adults in the United States has some form of chronic kidney disease, according to the Centers for Disease Control and Prevention. Hundreds of thousands are on dialysis, dependent on drugs manufactured by companies like Fresenius Medical Care to remove toxins from their blood. The procedure is time consuming and dangerous enough without the medications themselves doing more harm than good. A report made public just last year shows Fresenius may have withheld critical information from patients and doctors about the dangers of its dialysis meds, particularly GranuFlo and NaturaLyte, stated in an article from the New York Times. The potential for a massive number of patients to suffer life-threatening injuries has Philadelphia attorney Richard P. Console Jr. calling for greater accountability.

“To sit on the knowledge that your products could cause potentially lethal complications for patients is shocking behavior,” said Console. “It’s not as though it’s an independent report from an outside source. This is the company’s own medical office saying there’s a high risk of adverse, deadly events associated with their dialysis medications. There could be thousands of victims out there in real need of help.”

Fresenius Medical Care treats an estimated 400,000 dialysis patients in the United States, according to the New York Times. The company is also the leading supplier of dialysis machines and one-use dialysis products. Clinics around the country, including the company’s own facilities, use them every day. Fresenius’ internal memo, originally circulated in 2011, reportedly revealed a sharp increase in the number of sudden cardiac arrests in patients using GranuFlo.

The memo claimed 941 patients suffered cardiac arrest while inside Fresenius clinics in 2010, which the company’s medical team attributed to high levels of bicarbonate in their blood. Acetate ingredients in GranuFlo and other dialysis products made by Fresenius reportedly led to the spikes in bicarbonate, which caused a six-fold increase in the risk of cardiac arrest. Console, whose law firm has been practicing in the Philadelphia area since 1994, believes these events were preventable.

“The company had an opportunity to get out in front of this issue, warn patients, and inform doctors to alter dialysis treatment plans,” Console said. “From all the information available, it doesn’t appear that was done, and people may have suffered significantly because of that failure. Victims deserve compensation for the pain and serious injuries they’ve endured. Losing a loved one to a preventable condition is unacceptable, especially when there’s evidence to suggest the company knew the problem existed long before they did anything to stop it.”

On the heels of an investigation by the U.S. Food and Drug Administration (FDA) into Fresenius’ delay in informing the public about known risks of its products, the company issued a Class I recall of GranuFlo and NaturaLyte in June 2012. A Class I recall is the most serious form of drug recall, used only when a product presents a probable risk of harm to patients.

Richard P. Console Jr. is the managing partner of Console & Hollawell P.C., a personal injury law firm that has helped more than 5,000 victims in Philadelphia, including those affected by defective medical products, obtain the compensation they deserve.    

http://www.nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html?_r=0

http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/

Read the full story at http://www.prweb.com/releases/2013/2/prweb10405530.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Inside a machine for turning coffee into science
2. New Novel Looks at British NHS from the Inside
3. Fitness Celebrity and one of Canada’s Inside Fitness Hot and Fit Women of 2012, Nancy Di Nino, brings her Media Personality to host the Hot & Fit Release Party
4. Corporate Whistle Blower Center Now Urges Physicians Medical Device and Drug Industry Insiders To Step Up-If They Have Proof Of Serious Wrongdoing or Overbilling
5. Corporate Whistle Blower Center Now Urges Physicians, Medical Device or Drug Insiders With Proof A Company Knowingly Sold A Bad Product to Become a Whistleblower
6. Prime Medical Associates’ Sleep Lab Featured in Insider Magazine
7. Skin Authority Creates One-of-a-Kind Solution for the One Billion People Worldwide Who are Vitamin D Deficient -- Groundbreaking Launch of "Inside Out" System
8. Corporate Whistle Blower Center Now Urges Medical Industry Insiders to Blow the Whistle if They Can Prove a Medical Product was Defective and Their Company Sold it Anyway
9. New MRI technology to provide even better images of the inside of the human body
10. Smart scaffolding aims to rebuild tissue from the inside
11. Parents skin cancer concern doesnt keep kids inside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: